Search Results - Chuhan Chung

Refine Results
  1. 1
    The lymphatic vascular system in liver diseases: its role in ascites formation

    The lymphatic vascular system in liver diseases: its role in ascites formation by Chuhan Chung, Yasuko Iwakiri

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis

    Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis by Chuhan Chung, Jeanne Gottstein, Andrés T. Blei

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy

    Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy by Javier Vaquero, Chuhan Chung, Andrés T. Blei

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Infection and the progression of hepatic encephalopathy in acute liver failure

    Infection and the progression of hepatic encephalopathy in acute liver failure by Javier Vaquero, Julie Polson, Chuhan Chung, Irene Helenowski, Frank Vinholt Schiødt, Joan Reisch, William M. Lee, Andrés T. Blei

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer

    The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer by Chuhan Chung, Christopher C. Mader, John C. Schmitz, Jórunn Atladóttir, P Fitchev, Mona Cornwell, Anthony J. Koleske, Susan E. Crawford, Fred S. Gorelick

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Determination of mesenchymal stem cell fate by pigment epithelium‐derived factor (PEDF) results in increased adiposity and reduced bone mineral content

    Determination of mesenchymal stem cell fate by pigment epithelium‐derived factor (PEDF) results in increased adiposity and reduced bone mineral content by Arijeet K. Gattu, E. Scott Swenson, Yasuko Iwakiri, Varman T. Samuel, Nancy Troiano, Ryan Berry, Christopher Church, Matthew S. Rodeheffer, Thomas O. Carpenter, Chuhan Chung

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    An endoplasmic reticulum protein, Nogo‐B, facilitates alcoholic liver disease through regulation of kupffer cell polarization

    An endoplasmic reticulum protein, Nogo‐B, facilitates alcoholic liver disease through regulation of kupffer cell polarization by Jin‐Kyu Park, Mingjie Shao, Moon Young Kim, Soon Koo Baik, Mee-Yon Cho, Teruo Utsumi, Ayano Satoh, Xinsho Ouyang, Chuhan Chung, Yasuko Iwakiri

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat

    Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat by Eric Lawitz, Bal Raj Bhandari, Peter Ruane, Anita Kohli, Eliza Harting, Dora Ding, Jen‐Chieh Chuang, Ryan S. Huss, Chuhan Chung, Robert P. Myers, Rohit Loomba

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis

    Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis by Dahai Zhang, Teruo Utsumi, Hui‐Chun Huang, Lili Gao, Panjamaporn Sangwung, Chuhan Chung, Kazunori Shibao, Kohji Okamoto, Koji Yamaguchi, Roberto J. Groszmann, Levente József, Zhengrong Hao, William C. Sessa, Yasuko Iwakiri

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis

    DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis by Rohit Loomba, Yevgeniy Gindin, Zhaoshi Jiang, Eric Lawitz, Stephen H. Caldwell, C. Stephen Djedjos, Ren Xu, Chuhan Chung, Robert P. Myers, G. Mani Subramanian, Zachary Goodman, Michael Charlton, Nezam H. Afdhal, Anna Mae Diehl

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis

    PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with p... by Michael Trauner, Chuhan Chung, Kate Sterling, Xiangyu Liu, Xiaomin Lu, Jun Xu, Clare M. Tempany, Zachary Goodman, Martti Färkkilâ, Atsushi Tanaka, Palak Trivedi, Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, Robert P. Myers

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease

    GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease by Rohit Loomba, Zeid Kayali, Mazen Noureddin, Peter Ruane, Eric Lawitz, Michael Bennett, Lulu Wang, Eliza Harting, Jacqueline M. Tarrant, B. Mccolgan, Chuhan Chung, Adrian S. Ray, G. Mani Subramanian, Robert P. Myers, Michael S. Middleton, Michelle Lai, Michael Charlton, Stephen A. Harrison

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH

    En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH by Masaki Kimura, Takuma Iguchi, Kentaro Iwasawa, Andrew Dunn, Wendy L. Thompson, Yosuke Yoneyama, Praneet Chaturvedi, Aaron M. Zorn, Michelle Wintzinger, Mattia Quattrocelli, Miki Watanabe‐Chailland, Gaohui Zhu, Masanobu Fujimoto, Meenasri Kumbaji, Asuka Kodaka, Yevgeniy Gindin, Chuhan Chung, Robert P. Myers, G. Mani Subramanian, Vivian Hwa, Takanori Takebe

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

    The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis by Michael Trauner, Aliya Gulamhusein, Bilal Hameed, Stephen H. Caldwell, Mitchell L. Shiffman, Charles Landis, Bertus Eksteen, Kosh Agarwal, Andrew J. Muir, Simon Rushbrook, Xiaomin Lu, Jun Xu, Jen‐Chieh Chuang, Andrew N. Billin, Georgia Li, Chuhan Chung, G. Mani Subramanian, Robert P. Myers, Christopher L. Bowlus, Kris V. Kowdley

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH

    IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH by Jun Xu, Ya Wang, Mina Khoshdeli, Matt Peach, Jen‐Chieh Chuang, Julie Lin, Wen‐Wei Tsai, Sangeetha Mahadevan, Wesley Minto, Lauri Diehl, Ruchi Gupta, Michael Trauner, Keyur Patel, Mazen Noureddin, Kris V. Kowdley, Aliya Gulamhusein, Christopher L. Bowlus, Ryan S. Huss, Robert P. Myers, Chuhan Chung, Andrew N. Billin

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis

    Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis by Arun J. Sanyal, Quentin M. Anstee, Michael Trauner, Eric Lawitz, Manal F. Abdelmalek, Dora Ding, Ling Han, Catherine Jia, Ryan S. Huss, Chuhan Chung, Vincent Wai‐Sun Wong, Takeshi Okanoue, Manuel Romero‐Gómez, Andrew J. Muir, Nezam H. Afdhal, Jaime Bosch, Zachary Goodman, Stephen A. Harrison, Zobair M. Younossi, Robert P. Myers

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis

    A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis by Jaime Bosch, Chuhan Chung, Oscar Carrasco‐Zevallos, Stephen A. Harrison, Manal F. Abdelmalek, Mitchell L. Shiffman, Don C. Rockey, Zahil Shanis, Dinkar Juyal, Harsha Pokkalla, Quang Le, Murray B. Resnick, Michael Montalto, Andrew H. Beck, Ilan Wapinski, Ling Han, Catherine Jia, Zachary Goodman, Nezam H. Afdhal, Robert P. Myers, Arun J. Sanyal

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis

    Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis by Rohit Loomba, Daniel Q. Huang, Arun J. Sanyal, Quentin M. Anstee, Michael Trauner, Eric Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew N. Billin, Ryan S. Huss, Chuhan Chung, Zachary Goodman, Vincent Wai‐Sun Wong, Takeshi Okanoue, Manuel Romero‐Gómez, Manal F. Abdelmalek, Andrew J. Muir, Nezam H. Afdhal, Jaime Bosch, Stephen A. Harrison, Zobair M. Younossi, Robert P. Myers

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH

    A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH by Amaro Taylor‐Weiner, Harsha Pokkalla, Ling Han, Catherine Jia, Ryan S. Huss, Chuhan Chung, Hunter Elliott, Benjamin Glass, Kishalve Pethia, Oscar Carrasco‐Zevallos, Chinmay Shukla, Urmila Khettry, Robert M. Najarían, Ross Taliano, G. Mani Subramanian, Robert P. Myers, Ilan Wapinski, Aditya Khosla, Murray B. Resnick, Michael Montalto, Quentin M. Anstee, Vincent Wai‐Sun Wong, Michael Trauner, Eric Lawitz, Stephen A. Harrison, Takeshi Okanoue, Manuel Romero‐Gómez, Zachary Goodman, Rohit Loomba, Andrew H. Beck, Zobair M. Younossi

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases

    AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases by Janani S. Iyer, Dinkar Juyal, Quang Le, Zahil Shanis, Harsha Pokkalla, Maryam Pouryahya, Aryan Pedawi, S. Adam Stanford-Moore, Charles Biddle-Snead, Oscar Carrasco‐Zevallos, Mary Lin, Robert Egger, Sara Hoffman, Hunter Elliott, Kenneth Leidal, Robert P. Myers, Chuhan Chung, Andrew N. Billin, Timothy R. Watkins, Scott D. Patterson, Murray B. Resnick, Katy Wack, Jon Glickman, Alastair D. Burt, Rohit Loomba, Arun J. Sanyal, Ben Glass, Michael Montalto, Amaro Taylor‐Weiner, Ilan Wapinski, Andrew H. Beck

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: